On this page
Jun 12, 2026 ⋅ 7 min read

Inflammation Medication Side Effects, Risks, and Interactions

Common Side Effects

The administration of corticosteroids often results in predictable physiological changes due to their widespread effects on metabolic and homeostatic pathways. These side effects are frequently dose-dependent and may manifest shortly after treatment initiation.

Metabolic changes are common, characterized by shifts in glucose metabolism and appetite. Patients may observe weight gain, often concentrated in the face, neck, and abdomen. Increased appetite is another frequently reported outcome. Dermatological changes, such as thinning of the skin, easy bruising, or delayed wound healing, are documented in patients undergoing prolonged therapy.

Neuropsychiatric effects may also occur. These can range from insomnia and agitation to mood swings. Gastrointestinal irritation, such as dyspepsia or abdominal discomfort, is observed in a subset of patients. These effects are often managed by taking the medication with food or by utilizing concomitant acid-suppression therapy as directed by a healthcare professional.

Severe Adverse Reactions

While common side effects are often manageable, the systemic nature of these medications poses risks for severe adverse reactions, particularly during long-term use. The HPA (hypothalamic-pituitary-adrenal) axis may be suppressed, meaning the body’s endogenous production of cortisol is reduced. This necessitates a gradual tapering of the medication to allow the adrenal glands to resume normal function.

The suppression of the immune system increases susceptibility to infection. Pathogens that might be otherwise contained by the immune system can cause severe disease in patients taking these medications. Furthermore, chronic use is associated with a decrease in bone density, leading to an increased risk of osteoporosis and fractures.

Endocrine disturbances, specifically hyperglycemia or the development of steroid-induced diabetes, require monitoring. Patients with existing glucose intolerance may experience a worsening of their glycemic control. Ocular complications, including an increased risk of cataracts and elevated intraocular pressure (glaucoma), have also been linked to sustained corticosteroid exposure.

Contraindications and Precautions

The use of corticosteroids is contraindicated in specific clinical scenarios due to the risk of exacerbating underlying conditions. Patients with known hypersensitivity to the active ingredients—such as Methylprednisolone, Prednisolone, or Triamcinolone—should avoid these agents.

Systemic fungal infections represent a significant contraindication, as the immunosuppressive action of these medications can facilitate the proliferation of fungal pathogens. The use of live or live-attenuated vaccines is generally contraindicated in patients receiving immunosuppressive doses of corticosteroids, as the immune response to the vaccine may be insufficient, and the risk of disseminated infection from the vaccine virus is elevated.

Caution is required for patients with pre-existing cardiovascular conditions, as corticosteroids can cause fluid retention and electrolyte disturbances, such as hypokalemia. Patients with a history of gastrointestinal ulceration, renal impairment, or severe psychiatric disorders also require monitoring, as the administration of these agents may complicate the management of these conditions.

Drug-Drug Interactions

The pharmacokinetic and pharmacodynamic profiles of corticosteroids result in several notable medicine interactions. Understanding these interactions is necessary to prevent adverse outcomes and ensure therapeutic effectiveness.

The concurrent use of non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids increases the risk of gastrointestinal ulceration and bleeding. Both classes of medication possess individual irritant properties, and their combined use creates an additive risk profile.

Antidiabetic agents, including insulin and oral hypoglycemics, may have reduced effectiveness when taken alongside corticosteroids. The hyperglycemic effect of corticosteroids counteracts the action of glucose-lowering medications, necessitating more frequent blood glucose monitoring and potential dosage adjustments by a clinician.

Anticoagulants, such as warfarin, may show altered effectiveness when co-administered with corticosteroids. The anticoagulant response can be either diminished or enhanced, requiring vigilant monitoring of international normalized ratio (INR) levels. Additionally, drugs that induce hepatic enzymes, such as certain anticonvulsants, can increase the metabolism of corticosteroids, potentially reducing their therapeutic levels in the blood.

When to Seek Emergency Care

Certain symptoms occurring during treatment with inflammation medications indicate a need for immediate medical evaluation. If a patient experiences signs of an allergic reaction, such as difficulty breathing, swelling of the face or throat, or hives, emergency intervention is required.

Acute psychiatric disturbances, including severe confusion, hallucinations, or suicidal ideation, warrant prompt attention. Patients who develop signs of a severe infection—such as a high fever, chills, or localized redness and swelling that spreads rapidly—should be evaluated in an emergency setting.

Furthermore, if a patient on long-term corticosteroid therapy experiences sudden, severe abdominal pain, they should seek care to rule out gastrointestinal perforation, a rare but serious complication. Any sudden loss of vision or severe eye pain also necessitates an urgent clinical assessment.

Disclaimer: This article is for general information about medicine risks and does not replace medical advice, diagnosis, or treatment. Side effects, interactions, monitoring needs, and legal status can vary by medicine, person, and country. A qualified healthcare professional should be consulted before starting, stopping, or changing treatment. NSAIDs, corticosteroids, DMARDs, and biologics carry different risks, including stomach, kidney, cardiovascular, infection, and monitoring considerations.

Published Jun 11, 2026 · Updated Jun 12, 2026

Related Articles

Related topics

Categories

Generics